Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	17074
Country	Italy

Received	2015-02-11 08:59
Peer-Review Started	2015-02-13 20:13
To Make the First Decision	2015-03-06 10:09
Return for Revision	2015-03-15 19:01
Revised	2015-03-20 01:51
Second Decision	2015-06-10 14:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-06-19 18:04
Articles in Press	2015-06-19 18:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-29 17:26
Publish the Manuscript Online	2015-08-17 15:47

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Editorial
Article Title	Value of neoadjuvant chemotherapy in advanced ovarian cancer
Manuscript Source	Invited Manuscript
All Author List	Federico Coccolini, Fausto Catena, Roberto Manfredi, Giulia Montori, Jennifer E Manegold and Luca Ansaloni
Funding Agency and Grant Number
Corresponding Author	Federico Coccolini, MD, General and Emergency Surgery Department, Papa Giovanni XXIII Hospital, P.zza OMS 1, 24128 Bergamo, Italy. federico.coccolini@gmail.com
Key Words	Epithelial ovarian cancer; Neoadjuvant; Chemotherapy; Hyperthermic intraperitoneal chemo­therapy; Treatment; Oncology; Cytoreductive surgery
Core Tip	Data about the use of neoadjuvant chemo-therapy in advanced ovarian cancer are not sufficient to support its extensive application. However encouraging results came from the existing studies. Future well designed studies are needed to clarify some aspects of this chemotherapy regimen and its association with the other form of pharmacological and surgical therapy.
Publish Date	2015-08-17 15:47
Citation	Coccolini F, Catena F, Manfredi R, Montori G, Manegold JE, Ansaloni L. Value of neoadjuvant chemotherapy in advanced ovarian cancer. World J Obstet Gynecol 2015; 4(3): 64-67
URL	http://www.wjgnet.com/2218-6220/full/v4/i3/64.htm
DOI	http://dx.doi.org/10.5317/wjog.v4.i3.64

Full Article (PDF)	WJOG-4-64.pdf
Full Article (Word)	WJOG-4-64.doc
Manuscript File	17074-Review.doc
Answering Reviewers	17074-Answering reviewers.pdf
Audio Core Tip	17074-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	17074-Conflict-of-interest statement.pdf
Copyright License Agreement	17074-Copyright assignment.pdf
Peer-review Report	17074-Peer-review(s).pdf
Scientific Misconduct Check	17074-Scientific misconduct check.pdf
Scientific Editor Work List	17074-Scientific editor work list.pdf